The Union - North America Region

Highlights from End TB 2019: 23rd Annual Conference of The Union-North America Region

The 23rd Annual “The Union-North America Region” TB conference was held in Vancouver, British Columbia, Canada from February 21 to 23, 2019.  The event was attended by 300 international participants from various disciplines.  There were 128 abstracts submitted thru the call for abstracts and 123 were accepted for poster presentation at the conference. Six abstracts were chosen for oral presentation, and 14 were provided support via travel grants.  Three of the travel grant recipients were based outside North America.

Conference highlights included the George Comstock Lecture by Dr. Eric Goosby, the UN Special Envoy on Tuberculosis on the next steps following the UN High Level Meeting on TB, and The Beyond TB Lecture on the opioid crisis by Dr. Patricia Daly, Chief Medical Health Officer and Vice President, Public Health for Vancouver Coastal Health.  Two other noteworthy features at the conference were the laboratory post-graduate course facilitated by Dr. Max Salfinger, and a learning circle facilitated by Indigenous leaders and elders.  The Lifetime Achievement Award was presented to Dr. Andrew A. Vernon from the U.S. Centers for Disease Control and Prevention.

The conference will return to Chicago in 2020 and to Vancouver in 2021.

Download Abstract Book

NAR Executive Committee


2019 Travel Grant Recipients

Fourteen travel grants were awarded at the 23rd Annual Conference of The Union-North America Region. Click here to view the profiles of this year's awardees


Presentation Slides - February 20, 2019

Post-Graduate Course

Tuberculosis Immunology: Latest Developments - Dr. David Lewinsohn, Oregon Health & Science University

Therapeutic Drug Monitoring of Newer Compounds - Dr. Charles Peloquin, University of Florida

Nontuberculous Mycobacteria and the Environment - Dr. Jennifer R. Honda, National Jewish Health

Population Genomics of the M. tuberculosis Complex - Dr. Sebastien Gagneux, Swiss Tropical and Public Health Institute

Presentation Slides - February 21, 2019

Stop TB

TB Elimination among the Inuit of Canada - President Natan Obed, Inuit Tapiriit Kanatami

Can We End Tuberculosis? - Dr. Jennifer Flood, California Department of Public Health

Nursing-Sponsored Session

Engaging a Nunavut Community to Address Tuberculosis - Ms. Mishael Gordon, Government of Nunavut and Mrs. Daisy Arnaquq, Municipality of Qikiqtarjuaq

The Struggle for Structural Competency in Outreach and Care: Key Lessons from Ethnographic Research in a Marshallese TB Clinic - Mr. Caleb Klipowicz, University of Iowa

HIV Stigma and Potential Lessons for TB Stigma: Reflections and Implementation Experiences from Two Decades of HIV Stigma Work - Dr. Laura Nyblade, RTI International

Presentation Slides - February 22, 2019

Top 10 Updates in TB from 2018

TB Drugs: PK Update - Dr. Kelly Dooley, Johns Hopkins School of Medicine

TB Laboratory Update - Dr. Max Salfinger, University of South Florida

U.S. Preventive Services Task Force Update: Mobilizing Primary Care Physicians for LTBI Testing and Treatment - Dr. Nick DeLuca, U.S. Centers for Disease Control and Prevention

The Beyond TB Lecture

The Opioid Overdose Crisis: Role of the TB Physician - Dr. Patricia Daly, Vancouver Coastal Health

LTBI Treatment in Special Populations

3, 4, or 9 Months of Living Dangerously? Revisiting Benefits and Risks of LTBI Treatment - Dr. Kevin Schwartzman, McGill University

LTBI Treatment in Pregnancy - Dr. Sylvia LaCourse, University of Washington

LTBI Treatment in non–HIV Immunosuppressed Patients - Dr. Richard Zuckerman, Dartmouth-Hitchcock/Dartmouth Geisel School of Medicine

Patient-Centered Approaches to LTBI Treatment for “Challenging” Patients - Dr. Courtney Yuen, Brigham and Women’s Hospital/Harvard Medical School

Presentation Slides - February 23, 2019

TB Drug Development and Regimens: A Clinical Trials Update

New Drugs and Regimens for Treatment of Drug-Sensitive TB (DS-TB) - Dr. Patrick Phillips, University of California, San Francisco

New Drugs and Regimens for Drug-Resistant TB - Dr. C. Robert Horsburgh, Jr., Boston University School of Public Health

ACTG TB Transformative Science Group Protocol Updates - Dr. Kelly Dooley, Johns Hopkins School of Medicine

TB and Human Rights: The Pathways for Health Equity for Aboriginal Peoples

Two Row Wampum, Human Rights and the Elimination of Tuberculosis from High-Incidence Indigenous Communities - Dr. Richard Long, University of Alberta; Courtney Heffernan; Melissa Cardinal-Grant; Barbara George; Diane Janvier

The Latest in TB Prevention

TB Vaccines: The Glass Half Full - Dr. David Lewinsohn, Oregon Health & Science University

Effectiveness and Safety of 4 Months of Daily Rifampin vs. 9 Months of Daily Isoniazid: Results of the 4v9 Trials - Dr. Jonathon Campbell, McGill International TB Centre

LTBI Treatment Trials: Where are We and What’s Next - Dr. Bob Belknap, Denver Public Health


NAR Charter

Read the Charter of the North America Region of The Union.


Past Meeting Archives:

Page Last Updated: 21/03/2019